Sofinnova Ventures
Latest statistics and disclosures from Sofinnova Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are KRTX, NTRA, AVTE, ASND, SNY, and represent 50.13% of Sofinnova Investments's stock portfolio.
- Added to shares of these 10 stocks: HZNP (+$47M), ASND (+$47M), VRTX (+$45M), ALNY (+$37M), SNY (+$34M), ALGN (+$18M), SRPT (+$14M), KDNY (+$14M), CYTK (+$13M), IMTX (+$13M).
- Started 5 new stock positions in KURA, HZNP, VRTX, ALGN, ALNY.
- Reduced shares in these 10 stocks: QQQ (-$40M), , IWM (-$33M), MRK (-$31M), GILD (-$30M), , IRTC (-$18M), UTHR (-$16M), LLY (-$15M), .
- Sold out of its positions in ACET, Akouos, ARQT, EW, GILD, IRTC, INSM, QQQ, ISRG, IWM. LLY, NGM, RGNX, XLV.
- Sofinnova Investments was a net buyer of stock by $49M.
- Sofinnova Investments has $1.7B in assets under management (AUM), dropping by -1.95%.
- Central Index Key (CIK): 0001631134
Tip: Access up to 7 years of quarterly data
Positions held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 46 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Karuna Therapeutics Ord (KRTX) | 24.2 | $407M | 2.1M | 196.50 | ||
| Natera (NTRA) | 7.4 | $125M | 3.1M | 40.17 | ||
| Aerovate Therapeutics (AVTE) | 6.5 | $110M | 3.8M | 29.30 | ||
| Ascendis Pharma A/S Sponsored Adr (ASND) | 6.4 | $108M | +76% | 881k | 122.13 | |
| Sanofi SA Sponsored Adr (SNY) | 5.6 | $95M | +55% | 2.0M | 48.43 | |
| Cincor Pharma (CINC) | 4.4 | $75M | 6.1M | 12.29 | ||
| Merck & Co (MRK) | 4.0 | $67M | -31% | 603k | 110.95 | |
| Vera Therapeutics Cl A (VERA) | 3.7 | $62M | 3.2M | 19.35 | ||
| Horizon Therapeutics SHS (HZNP) | 2.8 | $47M | NEW | 413k | 113.80 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.7 | $45M | NEW | 157k | 288.78 | |
| AstraZeneca Sponsored Adr (AZN) | 2.5 | $42M | -12% | 614k | 67.80 | |
| BioMarin Pharmaceutical (BMRN) | 2.4 | $41M | +33% | 395k | 103.49 | |
| Reata Pharmaceuticals Cl A (RETA) | 2.2 | $38M | +21% | 992k | 37.99 | |
| Alnylam Pharmaceuticals Call Option (ALNY) | 2.2 | $37M | NEW | 156k | 237.65 | |
Setup an alertSofinnova Ventures will file the next quarterly 13-HR in about 2 months. Would you like to be notified? |
||||||
| Sarepta Therapeutics (SRPT) | 1.9 | $32M | +75% | 248k | 129.58 | |
| Cti Biopharma (CTIC) | 1.8 | $30M | +38% | 5.0M | 6.01 | |
| Cytokinetics Call Option (CYTK) | 1.7 | $28M | +89% | 609k | 45.82 | |
| Inhibrx (INBX) | 1.6 | $27M | +38% | 1.1M | 24.64 | |
| United Therapeutics Corporation (UTHR) | 1.5 | $25M | -39% | 89k | 278.09 | |
| Chinook Therapeutics (KDNY) | 1.3 | $21M | +180% | 807k | 26.20 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.2 | $20M | +72% | 1.0M | 20.14 | |
| Prometheus Biosciences (RXDX) | 1.2 | $19M | +26% | 177k | 110.00 | |
| Syndax Pharmaceuticals (SNDX) | 1.1 | $18M | +33% | 703k | 25.45 | |
| Align Technology (ALGN) | 1.0 | $18M | NEW | 83k | 210.90 | |
| Immatics NV SHS (IMTX) | 1.0 | $17M | +275% | 2.0M | 8.71 | |
| Dex (DXCM) | 0.9 | $16M | -31% | 141k | 113.24 | |
| Iveric Bio (ISEE) | 0.8 | $14M | -22% | 638k | 21.41 | |
| Travere Therapeutics (TVTX) | 0.7 | $12M | +46% | 578k | 21.03 | |
| Y Mabs Therapeutics (YMAB) | 0.6 | $11M | 2.2M | 4.88 | ||
| Agenus Call Option (AGEN) | 0.6 | $10M | +70% | 4.2M | 2.40 | |
| Geron Corporation (GERN) | 0.5 | $9.3M | +69% | 3.8M | 2.42 | |
| Ideaya Biosciences (IDYA) | 0.5 | $8.6M | -27% | 475k | 18.17 | |
| ImmunoGen (IMGN) | 0.5 | $8.4M | +235% | 1.7M | 4.96 | |
| Kura Oncology (KURA) | 0.4 | $7.4M | NEW | 594k | 12.41 | |
| Arcus Biosciences Incorporated (RCUS) | 0.4 | $6.5M | -17% | 315k | 20.68 | |
| Fulcrum Therapeutics (FULC) | 0.3 | $4.6M | -20% | 631k | 7.28 | |
| Galera Therapeutics (GRTX) | 0.3 | $4.6M | 3.1M | 1.49 | ||
| Inozyme Pharma (INZY) | 0.2 | $3.8M | 3.7M | 1.05 | ||
| Nextcure (NXTC) | 0.2 | $3.8M | 2.7M | 1.41 | ||
| Nucana Sponsored Adr (NCNA) | 0.2 | $3.7M | 5.6M | 0.66 | ||
| Bolt Biotherapeutics (BOLT) | 0.2 | $3.6M | 2.8M | 1.30 | ||
| Pds Biotechnology Ord (PDSB) | 0.1 | $1.9M | 143k | 13.20 | ||
| Nucana Common Shares | 0.1 | $1.6M | 2.4M | 0.66 | ||
| Obseva Sa (OBSV) | 0.0 | $689k | 4.7M | 0.14 | ||
| Synlogic (SYBX) | 0.0 | $437k | 575k | 0.76 | ||
| Fusion Pharmaceuticals (FUSN) | 0.0 | $369k | 117k | 3.15 | ||
Past Filings by Sofinnova Investments
SEC 13F filings are viewable for Sofinnova Investments going back to 2018
- Sofinnova Investments 2022 Q4 filed Feb. 14, 2023
- Sofinnova Investments 2022 Q3 filed Nov. 8, 2022
- Sofinnova Investments 2022 Q2 filed Aug. 15, 2022
- Sofinnova Investments 2022 Q1 filed May 16, 2022
- Sofinnova Investments 2021 Q4 filed Feb. 14, 2022
- Sofinnova Investments 2021 Q3 filed Nov. 15, 2021
- Sofinnova Investments 2021 Q2 filed Aug. 16, 2021
- Sofinnova Investments 2021 Q1 filed May 14, 2021
- Sofinnova Investments 2020 Q4 filed Feb. 16, 2021
- Sofinnova Investments 2020 Q3 filed Nov. 13, 2020
- Sofinnova Investments 2020 Q2 filed Aug. 13, 2020
- Sofinnova Investments 2020 Q1 filed May 13, 2020
- Sofinnova Investments 2019 Q4 filed Feb. 14, 2020
- Sofinnova Investments 2019 Q3 filed Nov. 14, 2019
- Sofinnova Investments 2019 Q2 filed Aug. 13, 2019
- Sofinnova Investments 2019 Q1 filed May 15, 2019